MedTrace Logo

Polish Revision Obesity Surgery Study

NCT05108532 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2021-11-05

No results posted yet for this study

Summary

Bariatric surgery is well established method of treating patients with obesity. Obesity is well-documented risk factor for many health conditions including some cancer, cardiovascular diseases, pulmonary diseases and type-2 diabetes. Bariatric surgery is associated with improved comorbidities, quality of life and survival in severe obesity. However, the rate of conversion or revisional bariatric surgeries is increasing nowadays. Recent date estimate the rate of revisional procedures between 8-25% of all bariatric surgeries performed worldwide.

Weight recidivism or fail to achieve a significant weight loss (estimated 10-20% of operated patients) remains a challenge for surgeons and patients. This has economic and health implications, leading to reduction in quality of life and increased prevalence of obesity-related comorbid conditions. Therefore, the aim of this study is to identified patients with failure after primary bariatric procedure in population of Poland.

Conditions

  • Metabolic Disease
  • Obesity, Morbid

Sponsors & Collaborators

  • University of Warmia and Mazury in Olsztyn

    collaborator OTHER

  • Jagiellonian University

    collaborator OTHER

  • Medical University in Białystok

    collaborator UNKNOWN

  • Nicolaus Copernicus University

    collaborator OTHER

  • Military Institute od Medicine National Research Institute

    collaborator OTHER

  • Medical University of Gdansk

    lead OTHER

Principal Investigators

  • Monika Proczko-Stepaniak, Prof · Medical University of Gdansk

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108532 on ClinicalTrials.gov